Detalhe da pesquisa
1.
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.
Blood
; 136(25): 2905-2917, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33331927
2.
Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapy.
Cytotherapy
; 24(8): 802-817, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589475
3.
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-ß.
Mol Ther Methods Clin Dev
; 27: 415-430, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36381305
4.
Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy.
Expert Rev Clin Immunol
; 17(6): 643-659, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821731
5.
NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.
Transplant Cell Ther
; 27(1): 21-35, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007496